Fordyce Marshall
SEC CIK 1859453 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | Pres, CEO, Dir | 253.7K | — | $23.74M | 58 | 2022-08-12 | 2026-09-15 |
Most active insiders at VERA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fordyce Marshall | Pres AND CEO, Dir | — | $9.73M |
| 2 | Turner William D. | Chief Regulatory Off | — | $1.45M |
| 3 | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | — | $566.8K |
| 4 | ENRIGHT PATRICK G | Dir | $250.0K | — |
| 5 | Grant Sean | CFO | — | $207.8K |
| 6 | JOHNSON DAVID LEE | COO | — | $108.3K |
| 7 | Carter Jason S | CLO | — | $107.5K |
| 8 | Brenner Robert | Chief Medical Off | — | $90.3K |
| 9 | Skelton Laurence Matthew | Chief Commercial Off | — | $66.4K |
| 10 | Boman Nancy Lee | Chief Regulatory Off | — | — |
Transactions 58
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-17 16:28 | 2026-09-15 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +18.5K | 253.7K | +8% | +$53.6K |
| DT | 2026-09-17 16:28 | 2026-09-15 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $37.00 | -18.5K | 235.2K | -7% | -$684.5K |
| DT | 2026-09-04 16:15 | 2026-09-02 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +18.5K | 253.7K | +8% | +$53.6K |
| DT | 2026-09-04 16:15 | 2026-09-02 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $35.12 | -18.5K | 235.2K | -7% | -$649.6K |
| DAT | 2026-08-12 18:42 | 2026-07-07 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +46.2K | 281.5K | +20% | +$134.0K |
| DMAT | 2026-08-12 18:42 | 2026-07-07 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $42.30 | -46.2K | 235.2K | -16% | -$1.96M |
| DAT | 2026-08-12 18:41 | 2026-06-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +18.5K | 253.7K | +8% | +$53.6K |
| DMAT | 2026-08-12 18:41 | 2026-06-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $37.93 | -18.5K | 235.2K | -7% | -$701.8K |
| DAT | 2026-08-12 18:39 | 2026-05-12 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +18.5K | 253.7K | +8% | +$53.6K |
| DMAT | 2026-08-12 18:39 | 2026-05-12 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $36.74 | -18.5K | 235.2K | -7% | -$679.7K |
| MT | 2026-07-09 16:45 | 2026-07-07 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $42.30 | -46.2K | 152.0K | -23% | -$1.96M |
| MT | 2026-06-24 16:55 | 2026-06-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $37.93 | -18.5K | 198.2K | -9% | -$701.8K |
| MT | 2026-05-13 16:26 | 2026-05-12 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $36.74 | -18.5K | 216.7K | -8% | -$679.7K |
| MT | 2026-04-15 16:57 | 2026-04-14 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $44.05 | -23.0K | 235.2K | -9% | -$1.01M |
| 2026-02-25 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $41.98 | -16.9K | 257.2K | -6% | -$710.5K | |
| D | 2026-02-06 | 2026-02-04 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | A - Grant | $0.00 | +68.8K | 274.1K | +34% | $0 |
| M | 2025-02-27 | 2025-02-21+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $27.78 | -19.7K | 204.7K | -9% | -$546.9K |
| D | 2025-02-20 | 2025-02-18 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | A - Grant | $0.00 | +80.8K | 224.4K | +56% | $0 |
| DM | 2025-01-10 | 2025-01-08 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +17.5K | 149.3K | +13% | +$50.8K |
| DM | 2025-01-10 | 2025-01-08 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $41.74 | -17.5K | 143.6K | -11% | -$730.5K |
| DM | 2024-12-20 | 2024-12-18+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +75.2K | 91.0K | +476% | +$218.0K |
| DM | 2024-12-20 | 2024-12-18 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $43.07 | -17.5K | 85.9K | -17% | -$753.7K |
| DM | 2024-12-13 | 2024-12-11 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $46.94 | -17.5K | 85.9K | -17% | -$821.5K |
| DM | 2024-12-13 | 2024-12-11 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +17.5K | 87.7K | +25% | +$50.8K |
| DM | 2024-11-27 | 2024-11-25 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $47.98 | -19.4K | 85.9K | -18% | -$929.5K |
| DM | 2024-11-27 | 2024-11-25 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +19.4K | 93.6K | +26% | +$56.2K |
| DM | 2024-11-15 | 2024-11-13 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $49.50 | -30.6K | 85.9K | -26% | -$1.52M |
| DM | 2024-11-15 | 2024-11-13 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +30.6K | 89.2K | +52% | +$88.8K |
| DM | 2024-10-25 | 2024-10-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $40.40 | -19.4K | 308.0K | -6% | -$782.7K |
| DM | 2024-10-25 | 2024-10-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +19.4K | 310.3K | +7% | +$56.2K |
| DM | 2024-10-11 | 2024-10-09 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $38.24 | -15.6K | 308.0K | -5% | -$597.5K |
| DM | 2024-10-11 | 2024-10-09 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +15.6K | 320.2K | +5% | +$45.3K |
| DM | 2024-09-27 | 2024-09-25 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +23.1K | 308.9K | +8% | +$67.1K |
| DM | 2024-09-27 | 2024-09-25 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $46.05 | -23.1K | 308.0K | -7% | -$1.06M |
| DM | 2024-09-13 | 2024-09-11 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $37.50 | -15.6K | 308.0K | -5% | -$586.0K |
| DM | 2024-09-13 | 2024-09-11 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +15.6K | 317.2K | +5% | +$45.3K |
| DM | 2024-08-30 | 2024-08-28 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $36.84 | -30.3K | 308.7K | -9% | -$1.12M |
| DM | 2024-08-30 | 2024-08-28 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +15.6K | 323.4K | +5% | +$45.3K |
| 2024-08-23 | 2024-08-21 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale | $39.76 | -14.5K | 322.7K | -4% | -$575.4K | |
| D | 2024-08-16 | 2024-08-14 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | M - OptEx | $2.90 | +15.6K | 352.8K | +5% | +$45.3K |
| D | 2024-08-16 | 2024-08-14 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | S - Sale+OE | $37.56 | -15.6K | 337.1K | -4% | -$586.9K |
| D | 2024-01-18 | 2024-01-16 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres AND CEO, Dir | A - Grant | $0.00 | +78.8K | 335.6K | +31% | $0 |
| DM | 2024-01-03 | 2023-12-29 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.88 | +13.5K | 256.9K | +6% | +$38.9K |
| 2023-08-23 | 2023-08-21 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | S - Sale | $16.66 | -5,210 | 243.4K | -2% | -$86.8K | |
| DM | 2022-11-17 | 2022-11-16 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.85 | +65.2K | 246.3K | +36% | +$186.0K |
| DM | 2022-10-05 | 2022-10-03+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.90 | +32.0K | 192.5K | +20% | +$92.8K |
| DM | 2022-10-05 | 2022-10-03+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | S - Sale+OE | $20.90 | -32.0K | 181.2K | -15% | -$668.8K |
| DM | 2022-09-14 | 2022-09-13 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | S - Sale+OE | $21.16 | -22.4K | 181.2K | -11% | -$473.2K |
| DM | 2022-09-14 | 2022-09-13 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.90 | +22.4K | 191.3K | +13% | +$64.9K |
| DM | 2022-09-13 | 2022-09-09+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.90 | +29.0K | 194.0K | +18% | +$84.2K |
| DM | 2022-09-13 | 2022-09-09+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | S - Sale+OE | $20.43 | -29.0K | 181.2K | -14% | -$592.8K |
| DM | 2022-09-09 | 2022-09-07+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.90 | +21.9K | 196.3K | +13% | +$63.5K |
| DM | 2022-09-09 | 2022-09-07+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | S - Sale+OE | $20.37 | -21.9K | 181.2K | -11% | -$445.9K |
| DM | 2022-09-06 | 2022-09-01+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.90 | +34.2K | 198.2K | +21% | +$99.2K |
| DM | 2022-09-06 | 2022-09-01+ | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | S - Sale+OE | $21.09 | -34.2K | 181.2K | -16% | -$721.3K |
| 2022-08-23 | 2022-08-19 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | A - Grant | $0.00 | +43.8K | 181.2K | +32% | $0 | |
| D | 2022-08-15 | 2022-08-12 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | S - Sale+OE | $20.16 | -20.5K | 137.4K | -13% | -$413.8K |
| D | 2022-08-15 | 2022-08-12 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Pres, CEO, Dir | M - OptEx | $2.90 | +20.5K | 157.9K | +15% | +$59.5K |
Purchase Sale Sale after option exercise All abbreviations